[HTML][HTML] Development and usability testing of Understanding Stroke, a tailored life-sustaining treatment decision support tool for stroke surrogate decision makers

EP Chen, C Arslanian-Engoren, W Newhouse… - BMC Palliative Care, 2020 - Springer
Background Surrogate decision makers of stroke patients are often unprepared to make
critical decisions on life-sustaining treatments. We describe the development process and …

[HTML][HTML] Development and usability testing of Understanding Stroke, a tailored life-sustaining treatment decision support tool for stroke surrogate decision makers

EP Chen, C Arslanian-Engoren… - BMC …, 2020 - bmcpalliatcare.biomedcentral.com
Surrogate decision makers of stroke patients are often unprepared to make critical decisions
on life-sustaining treatments. We describe the development process and key features for the …

Development and usability testing of Understanding Stroke, a tailored life-sustaining treatment decision support tool for stroke surrogate decision makers

EP Chen, C Arslanian-Engoren… - BMC Palliative …, 2020 - search.proquest.com
Background Surrogate decision makers of stroke patients are often unprepared to make
critical decisions on life-sustaining treatments. We describe the development process and …

Development and usability testing of Understanding Stroke, a tailored life-sustaining treatment decision support tool for stroke surrogate decision makers

EP Chen, C Arslanian-Engoren… - BMC palliative …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Surrogate decision makers of stroke patients are often unprepared to make
critical decisions on life-sustaining treatments. We describe the development process and …

Development and usability testing of Understanding Stroke, a tailored life-sustaining treatment decision support tool for stroke surrogate decision makers.

EP Chen, C Arslanian-Engoren… - BMC Palliative …, 2020 - search.ebscohost.com
Background: Surrogate decision makers of stroke patients are often unprepared to make
critical decisions on life-sustaining treatments. We describe the development process and …

[引用][C] Development and usability testing of Understanding Stroke, a tailored life-sustaining treatment decision support tool for stroke surrogate decision makers

EP Chen, C Arslanian-Engoren… - BMC Palliative Care …, 2020 - jglobal.jst.go.jp
Development and usability testing of Understanding Stroke , a tailored life-sustaining
treatment decision support tool for stroke surrogate decision makers | Article Information | J-GLOBAL …

Development and usability testing of Understanding Stroke, a tailored life-sustaining treatment decision support tool for stroke surrogate decision makers

EP Chen, C Arslanian-Engoren, W Newhouse… - 2020 - deepblue.lib.umich.edu
Background Surrogate decision makers of stroke patients are often unprepared to make
critical decisions on life-sustaining treatments. We describe the development process and …

Development and usability testing of Understanding Stroke, a tailored life-sustaining treatment decision support tool for stroke surrogate decision makers.

EP Chen, C Arslanian-Engoren, W Newhouse… - BMC Palliative …, 2020 - go.gale.com
Background Surrogate decision makers of stroke patients are often unprepared to make
critical decisions on life-sustaining treatments. We describe the development process and …

[PDF][PDF] Development and usability testing of Understanding Stroke, a tailored life-sustaining treatment decision support tool for stroke surrogate decision makers

EP Chen, C Arslanian-Engoren, W Newhouse… - 2020 - scholar.archive.org
Background: Surrogate decision makers of stroke patients are often unprepared to make
critical decisions on lifesustaining treatments. We describe the development process and …

[PDF][PDF] Development and usability testing of Understanding Stroke, a tailored life-sustaining treatment decision support tool for stroke surrogate decision makers

EP Chen, C Arslanian-Engoren, W Newhouse… - 2020 - d-nb.info
Background: Surrogate decision makers of stroke patients are often unprepared to make
critical decisions on lifesustaining treatments. We describe the development process and …